Human Epidermal Growth Factor Two (HER2) News Monitoring

Dr Gluz on Predictive Biomarkers for pCR With De-Escalated Chemo in HER2+ Breast Cancer

"There were several markers which are clearly predictive for pCR after 12 weeks [with de-escalated chemotherapy in patients with HR+ HER2+ early breast cancer]. For example, HER2 expression was found to be a clear predictive marker." Oleg Gluz, …

Breast Cancer Surgery Delay Associated With Increased Mortality

Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 days after diagnosis to have surgery, according to newly published research from the University of Oklahoma. The research team was …

VERITAC-2 Trial Shows Vepdegestrant Significantly Improves Survival in ESR1-Mutant Breast Cancer

Data from the Phase III VERITAC-2 trial (NCT05654623) found that vepdegestrant (ARV-471) monotherapy produced a significant improvement in progression-free survival (PFS) compared to fulvestrant treating patients with estrogen receptor 1-mutant (ESR1m) …

The Targeted Pulse: Excellent Advancements in Breast Cancer Management and an Extended Access Program for NMIBC

TMLI Plus Post-Transplant Cyclophosphamide Improves Transplant Outcomes in AML Administering total marrow and lymphoid irradiation at 20 Gy alongside post-transplant cyclophosphamide improved outcomes for patients with acute myeloid leukemia undergoing …

New breast cancer treatment will help prevent cancer from recurring, expert says

Breast cancer is the third most common type of cancer in Ireland almost 3,600 people are diagnosed every year. This form of cancer is also becoming more common, with cases are rising by about two to four percent every year. However, treatment for the …

Transforming breast cancer care

Breast cancer remains the most common cancer among women worldwide. While medical science has made significant progress, the journey remains complex, particularly for younger women. During a recent visit to Bangladesh, Dr Ma Jun, Consultant Medical …

Evolving Treatment Strategies in Early HER2+ Breast Cancer

Kadcyla Continues to Show Benefits in Early HER2+ Breast Cancer

Among patients with HER2-positive early breast cancer, treatment with Kadcyla (ado-trastuzumab emtansine, T-DM1) has continued to show sustained improvement in both invasive disease-free survival and overall survival when compared with Herceptin ( …

Study Validates Effectiveness of KYAN Tech's Platform for Combination Therapy Prediction and Target Discovery in Sarcoma

Groundbreaking study published in npj Precision Oncology highlights Optim.AI’s potential to revolutionize personalized cancer treatment strategies SINGAPORE, SINGAPORE, March 24, 2025 /⁨EINPresswire.com⁩/ -- KYAN Technologies Pte. Ltd. (“KYAN”) …

Data Show Guideline-Concordant Care Gaps in Inflammatory Breast Cancer

Although receipt of guideline-concordant care (GCC) correlated with improved overall survival (OS) among those with nonmetastatic inflammatory breast cancer (IBC), most patients do not appear to receive all available types of GCC they are eligible for, …

BCYW Foundation Highlights Advances in Breast Cancer in Young Women from the 19th St Gallen Breast Cancer Conference2025

Highlights from the St. Gallen Breast Cancer Conference That Drive Progress for Young Women Facing Breast Cancer DENVER, CO, UNITED STATES, March 21, 2025 /⁨EINPresswire.com⁩/ -- The Breast Cancer in Young Women Foundation (BCYW Foundation) …

Tata Memorial research finds weak spot in aggressive cancer cells and an old drug to treat it

An invasive, aggressive and fast-spreading breast cancer, which is affecting younger Indian women, may just get easier to treat. Researchers at Tata Memorial have found a hidden weak spot or an Achilles’ heel in these stubborn cancer cells that can be …

Emphasizing the Importance of Breast Cancer Education and Screenings

At the recent 42nd Annual Miami Breast Cancer Conference and the Educated Patient Breast Cancer Summit, registered nurse Patricia Jakel sat down for an interview with CURE about the value of these meetings in keeping patients informed about the latest …

Selection of Frontline CDK4/6 Inhibitors Hinges on Patient Health Status in HR+/HER2– Metastatic Breast Cancer

In the hormone receptor (HR)–positive, HER2-negative metastatic breast cancer setting, frontline treatment with CDK4/6 inhibitor–based regimens are standard of care, and selecting between the approved CDK4/6 inhibitors should rely on patient- …

Angle updates on AstraZeneca development work and Eisai’s phase 2 pilot study

Angle Inc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample, has provided CTC analysis with its Parsortix-based HER2 assay …

If Patients Want A Better Quality Of Life, Why Isn't That A Focus For Pharma?

A conversation with Frédéric Fiteni, Ph.D., medical oncologist and oncology PRO specialist, University Hospital of Nîmes, and, member of Kayentis Scientific Advisory Board “Listen to patients,” or a similar adage, is often repeated by clinical research …

Patient Education Is Key to Improve Patient Adherence to Cancer Treatment

Keeping patients informed and educated is key to helping them achieve treatment adherence, says a registered nurse. Jessie Desir, PhD, RN, AMB-BC, OCN, spoke with Oncology Nursing News about how providers can aid in treatment adherence among patients with …

Innovative Tool Enhances the Efficacy of Cancer Immunotherapy

On the forefront of cancer research, a groundbreaking study has emerged, shedding light on how to enhance the efficacy of Natural Killer (NK) cells against malignant tumors. These specialized lymphocytes play an essential role in the immune system, armed …

Evolving Treatments and Advances in HER2-Positive Breast Cancer

In a presentation at the recent 42nd Annual Miami Breast Cancer Conference and the Educated Patient Breast Cancer Summit, Dr. Sara M. Tolaney gave a discussion on the topic of HER2-positive breast cancer for patients. In the discussion, she highlighted …

Mobility City's Technician Network, the Largest HME Repair & Delivery Network, is Now an Accredited Exemplary Provider

Mobility City's franchise system, with the largest HME repair and delivery Technician Network in the US, is now a CMS approved Exemplary Provider BOCA RATON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings Inc, …

Foreign Aid Bridge Fund Donations Surpass $1 Million

Emergency Funding Fuels Life-Saving Relief for Frontline Organizations Amid Rising Global Crises WASHINGTON, RI, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Foreign Aid Bridge Fund has surpassed $1 million in donations just over a …

Enkrypt AI Launches New Multimodal AI Security Solution to Safeguard Text, Image, and Voice AI Systems

Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA …

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee

Perry appointed to NASEM Committee on Clinical Follow-Up and Care for Those Impacted by the JP-5 Releases at Red Hill. FAIRFAX, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- As a widely respected researcher and public health leader, …

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Feroot Launches PaymentGuard AI: Automated PCI DSS 4 Compliance for Websites with E-commerce Payment Webpages.

PaymentGuard AI by Feroot Security: Automating PCI DSS 4 Compliance with Requirements 6.4.3 and 11.6.1 for SAQ D and SAQ A-EP E-Commerce Merchants. TORONTO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Feroot Security, a leader in cybersecurity …

PUSH for Empowered Pregnancy Launches #MomentForStillness to Honor Babies Born Still and Demand Urgent Action

A Nationwide Call to Address Preventable Stillbirths Begins March 25th at Noon ET NEW YORK, NY, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PUSH for Empowered Pregnancy is launching the #MomentForStillness campaign at noon ET on Tuesday, …

TravelingWiki Foundation Launches 'Card For a Cause' to Leverage Sports Cards for Free Non Visible Disability Resources

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian DES MOINES, IA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome Modulation

Brian Russon Named CEO, Kait Mikes Appointed COO as Company Advances Clinical Validation of Predictive Platform PALM SPRINGS, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PhenoBiome, Inc., a pioneering leader in personalized …

Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Former Power Plant Worker with Just Diagnosed ...

TAMPA , FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center says, "We have endorsed, and we highly recommend the Gori Law Firm for a former power plant worker with just diagnosed mesothelioma or …

OmnySense to Target Oncology Patients as Initial Focus for Its Transformative Personal Health-Assessment Solution

19m Americans have cancer. Unplanned acute visits drive nearly half the costs-creating a major unmet need and opportunity for innovative solutions TEL AVIV, ISRAEL, March 25, 2025 /⁨EINPresswire.com⁩/ -- OmnySense, an innovative digital health …

RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science

RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /⁨EINPresswire.com⁩/ -- RSU Research Week 2025 opened on 24 …

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Board of Atlas Antibodies Group is pleased to announce …

A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024

The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /⁨EINPresswire.com⁩/ -- The A' Wellness, Health Promotion …

Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders

BRADENTON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Acclaim Autism is thrilled to …

Helvetic Dental Clinics en Hongrie célèbre une année record en 2024 en tant que meilleure clinique dentaire de Budapest

Helvetic Dental Clinics, la meilleure clinique dentaire en Hongrie, termine 2024 sur un bilan record et agrandit sa capacité avec l’ajout de quatre fauteuils. BUDAPEST, BUDAPEST, HUNGARY, March 25, 2025 /⁨EINPresswire.com⁩/ -- Helvetic Dental …

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

CARLSBAD, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced that the U.S. Food and …

Chasin A Dream Foundation’s Annual Gala Raises Over $550,000 for Local Children Battling Life-Threatening Illnesses

The Jupiter based foundation's annual gala was an unforgettable evening of generosity and impact, breaking a record with $550,000 raised. JUPITER, FL, UNITED STATES, March 24, 2025 /⁨EINPresswire.com⁩/ -- Chasin A Dream Foundation’s annual …